310 related articles for article (PubMed ID: 18404411)
1. 'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.
Biegstraaten M; van Schaik IN; Aerts JM; Hollak CE
J Inherit Metab Dis; 2008 Jun; 31(3):337-49. PubMed ID: 18404411
[TBL] [Abstract][Full Text] [Related]
2. The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG).
Chérin P; Rose C; de Roux-Serratrice C; Tardy D; Dobbelaere D; Grosbois B; Hachulla E; Jaussaud R; Javier RM; Noël E; Clerson P; Hartmann A
J Inherit Metab Dis; 2010 Aug; 33(4):331-8. PubMed ID: 20532983
[TBL] [Abstract][Full Text] [Related]
3. Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease.
Donald A; Björkvall CK; Vellodi A; ; Cox TM; Hughes D; Jones SA; Wynn R; Machaczka M
Orphanet J Rare Dis; 2022 Jun; 17(1):234. PubMed ID: 35717194
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.
Biegstraaten M; Mengel E; Maródi L; Petakov M; Niederau C; Giraldo P; Hughes D; Mrsic M; Mehta A; Hollak CE; van Schaik IN
Brain; 2010 Oct; 133(10):2909-19. PubMed ID: 20693542
[TBL] [Abstract][Full Text] [Related]
5. Two cases of neuronopathic form of Gaucher disease - diagnostic difficulties.
Kleinotiene G; Ivaskeviciene A; Tylki-Szymanska A
Acta Biochim Pol; 2021 Dec; 69(1):119-122. PubMed ID: 34905319
[TBL] [Abstract][Full Text] [Related]
6. A neurological symptom survey of patients with type I Gaucher disease.
Pastores GM; Barnett NL; Bathan P; Kolodny EH
J Inherit Metab Dis; 2003; 26(7):641-5. PubMed ID: 14707512
[TBL] [Abstract][Full Text] [Related]
7. The Spectrum of Neurological Manifestations Associated with Gaucher Disease.
Roshan Lal T; Sidransky E
Diseases; 2017 Mar; 5(1):. PubMed ID: 28933363
[TBL] [Abstract][Full Text] [Related]
8. Neuronopathic forms of Gaucher's disease.
Erikson A; Bembi B; Schiffmann R
Baillieres Clin Haematol; 1997 Dec; 10(4):711-23. PubMed ID: 9497859
[TBL] [Abstract][Full Text] [Related]
9. Type 2 Gaucher disease: 15 new cases and review of the literature.
Mignot C; Doummar D; Maire I; De Villemeur TB;
Brain Dev; 2006 Jan; 28(1):39-48. PubMed ID: 16485335
[TBL] [Abstract][Full Text] [Related]
10. In-depth phenotyping for clinical stratification of Gaucher disease.
D'Amore S; Page K; Donald A; Taiyari K; Tom B; Deegan P; Tan CY; Poole K; Jones SA; Mehta A; Hughes D; Sharma R; Lachmann RH; Chakrapani A; Geberhiwot T; Santra S; Banka S; Cox TM;
Orphanet J Rare Dis; 2021 Oct; 16(1):431. PubMed ID: 34649574
[TBL] [Abstract][Full Text] [Related]
11. Gaucher disease and the synucleinopathies: refining the relationship.
Campbell TN; Choy FY
Orphanet J Rare Dis; 2012 Jan; 7():12. PubMed ID: 22289779
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics of the neurological forms of Gaucher's disease].
Capablo Liesa JL; de Cabezón AS; Alarcia Alejos R; Ara Callizo JR
Med Clin (Barc); 2011 Sep; 137 Suppl 1():6-11. PubMed ID: 22230119
[TBL] [Abstract][Full Text] [Related]
13. Severe cardiac involvement in Gaucher type IIIC: a case report and review of the literature.
Kör Y; Keskin M; Başpınar O
Cardiol Young; 2017 Sep; 27(7):1426-1429. PubMed ID: 28393750
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of Parkinson's syndrome in type I Gaucher disease.
Neudorfer O; Giladi N; Elstein D; Abrahamov A; Turezkite T; Aghai E; Reches A; Bembi B; Zimran A
QJM; 1996 Sep; 89(9):691-4. PubMed ID: 8917744
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
Ceravolo F; Grisolia M; Sestito S; Falvo F; Moricca MT; Concolino D
J Med Case Rep; 2017 Jan; 11(1):19. PubMed ID: 28103924
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder.
Winter AW; Salimi A; Ospina LH; Roos JCP
Br J Ophthalmol; 2019 Mar; 103(3):315-326. PubMed ID: 30612093
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.
Daykin EC; Ryan E; Sidransky E
Mol Genet Metab; 2021 Feb; 132(2):49-58. PubMed ID: 33483255
[TBL] [Abstract][Full Text] [Related]
18. [Gaucher disease: clinical, genetic and therapeutic aspects].
Germain DP
Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
[TBL] [Abstract][Full Text] [Related]
19. Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements.
Grabowski GA; Andria G; Baldellou A; Campbell PE; Charrow J; Cohen IJ; Harris CM; Kaplan P; Mengel E; Pocovi M; Vellodi A
Eur J Pediatr; 2004 Feb; 163(2):58-66. PubMed ID: 14677061
[TBL] [Abstract][Full Text] [Related]
20. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
